Efficacy and Safety of Antiepileptic Drugs in the Management of Behavioral Issues in Autism Spectrum Disorders: A Systematic Review and Meta-analysis

Background: Autism spectrum disorder (ASD) is often accompanied by comorbidities such as epilepsy and behavioral problems. The interplay between epilepsy, behavior, and language suggests a potential role for antiepileptic drugs (AEDs) in managing ASD-related behavioral issues. Despite some prelimina...

Full description

Saved in:
Bibliographic Details
Main Authors: Sowmyashree Mayur Kaku, Ananya Varshney, Dhwani Ravi, Ann Maria Moncy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Journal of Psychiatry Spectrum
Subjects:
Online Access:https://journals.lww.com/10.4103/jopsys.jopsys_33_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850170399087656960
author Sowmyashree Mayur Kaku
Ananya Varshney
Dhwani Ravi
Ann Maria Moncy
author_facet Sowmyashree Mayur Kaku
Ananya Varshney
Dhwani Ravi
Ann Maria Moncy
author_sort Sowmyashree Mayur Kaku
collection DOAJ
description Background: Autism spectrum disorder (ASD) is often accompanied by comorbidities such as epilepsy and behavioral problems. The interplay between epilepsy, behavior, and language suggests a potential role for antiepileptic drugs (AEDs) in managing ASD-related behavioral issues. Despite some preliminary studies indicating possible benefits, the evidence remains inconclusive. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of AEDs in managing behavioral issues in individuals with ASD. Methodology: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a comprehensive search across multiple databases (PubMed, Ovid MEDLINE, Cochrane Library, Web of Science, and others) for double-blind, placebo-controlled randomized controlled trials (RCTs) published in English. Inclusion criteria focused on individuals with ASD exhibiting behavioral problems, with or without EEG abnormalities, treated with AEDs. Data extraction and quality assessment were performed by two independent reviewers. The primary outcome was focused on investigating the efficacy of AEDs in improving behavioral symptoms, predominantly irritability, and aggression. We also investigated the safety profiles of the AEDs. Results: Seven RCTs met the inclusion criteria, involving AEDs such as valproate, levetiracetam, and topiramate. Two RCTs were excluded due to incompatible outcome measures. Meta-analysis of the remaining five RCTs showed no significant difference in the reduction of aggression and irritability between AEDs and placebo, with high heterogeneity (I2 = 93%). Sensitivity analysis confirmed the nonsignificance and high heterogeneity (I2 = 87%). Adverse effects commonly reported included insomnia and weight gain. Conclusion: This meta-analysis found no significant benefit of AEDs in managing behavioral symptoms of ASD compared to placebo, consistent with previous findings. The high heterogeneity and methodological limitations highlight the need for more robust and larger-scale studies. Future research should consider the role of electroencephalography abnormalities and standardize outcome measures to better evaluate the potential of AEDs in this population or in a specific subgroup of ASD.
format Article
id doaj-art-7a596abdf4fa4b22980866598bf9d3ad
institution OA Journals
issn 2949-6969
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Psychiatry Spectrum
spelling doaj-art-7a596abdf4fa4b22980866598bf9d3ad2025-08-20T02:20:30ZengWolters Kluwer Medknow PublicationsJournal of Psychiatry Spectrum2949-69692025-01-0141404910.4103/jopsys.jopsys_33_24Efficacy and Safety of Antiepileptic Drugs in the Management of Behavioral Issues in Autism Spectrum Disorders: A Systematic Review and Meta-analysisSowmyashree Mayur KakuAnanya VarshneyDhwani RaviAnn Maria MoncyBackground: Autism spectrum disorder (ASD) is often accompanied by comorbidities such as epilepsy and behavioral problems. The interplay between epilepsy, behavior, and language suggests a potential role for antiepileptic drugs (AEDs) in managing ASD-related behavioral issues. Despite some preliminary studies indicating possible benefits, the evidence remains inconclusive. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of AEDs in managing behavioral issues in individuals with ASD. Methodology: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a comprehensive search across multiple databases (PubMed, Ovid MEDLINE, Cochrane Library, Web of Science, and others) for double-blind, placebo-controlled randomized controlled trials (RCTs) published in English. Inclusion criteria focused on individuals with ASD exhibiting behavioral problems, with or without EEG abnormalities, treated with AEDs. Data extraction and quality assessment were performed by two independent reviewers. The primary outcome was focused on investigating the efficacy of AEDs in improving behavioral symptoms, predominantly irritability, and aggression. We also investigated the safety profiles of the AEDs. Results: Seven RCTs met the inclusion criteria, involving AEDs such as valproate, levetiracetam, and topiramate. Two RCTs were excluded due to incompatible outcome measures. Meta-analysis of the remaining five RCTs showed no significant difference in the reduction of aggression and irritability between AEDs and placebo, with high heterogeneity (I2 = 93%). Sensitivity analysis confirmed the nonsignificance and high heterogeneity (I2 = 87%). Adverse effects commonly reported included insomnia and weight gain. Conclusion: This meta-analysis found no significant benefit of AEDs in managing behavioral symptoms of ASD compared to placebo, consistent with previous findings. The high heterogeneity and methodological limitations highlight the need for more robust and larger-scale studies. Future research should consider the role of electroencephalography abnormalities and standardize outcome measures to better evaluate the potential of AEDs in this population or in a specific subgroup of ASD.https://journals.lww.com/10.4103/jopsys.jopsys_33_24antiepileptic drugsautism spectrum disorderbehavioral issuesmeta-analysissystematic review
spellingShingle Sowmyashree Mayur Kaku
Ananya Varshney
Dhwani Ravi
Ann Maria Moncy
Efficacy and Safety of Antiepileptic Drugs in the Management of Behavioral Issues in Autism Spectrum Disorders: A Systematic Review and Meta-analysis
Journal of Psychiatry Spectrum
antiepileptic drugs
autism spectrum disorder
behavioral issues
meta-analysis
systematic review
title Efficacy and Safety of Antiepileptic Drugs in the Management of Behavioral Issues in Autism Spectrum Disorders: A Systematic Review and Meta-analysis
title_full Efficacy and Safety of Antiepileptic Drugs in the Management of Behavioral Issues in Autism Spectrum Disorders: A Systematic Review and Meta-analysis
title_fullStr Efficacy and Safety of Antiepileptic Drugs in the Management of Behavioral Issues in Autism Spectrum Disorders: A Systematic Review and Meta-analysis
title_full_unstemmed Efficacy and Safety of Antiepileptic Drugs in the Management of Behavioral Issues in Autism Spectrum Disorders: A Systematic Review and Meta-analysis
title_short Efficacy and Safety of Antiepileptic Drugs in the Management of Behavioral Issues in Autism Spectrum Disorders: A Systematic Review and Meta-analysis
title_sort efficacy and safety of antiepileptic drugs in the management of behavioral issues in autism spectrum disorders a systematic review and meta analysis
topic antiepileptic drugs
autism spectrum disorder
behavioral issues
meta-analysis
systematic review
url https://journals.lww.com/10.4103/jopsys.jopsys_33_24
work_keys_str_mv AT sowmyashreemayurkaku efficacyandsafetyofantiepilepticdrugsinthemanagementofbehavioralissuesinautismspectrumdisordersasystematicreviewandmetaanalysis
AT ananyavarshney efficacyandsafetyofantiepilepticdrugsinthemanagementofbehavioralissuesinautismspectrumdisordersasystematicreviewandmetaanalysis
AT dhwaniravi efficacyandsafetyofantiepilepticdrugsinthemanagementofbehavioralissuesinautismspectrumdisordersasystematicreviewandmetaanalysis
AT annmariamoncy efficacyandsafetyofantiepilepticdrugsinthemanagementofbehavioralissuesinautismspectrumdisordersasystematicreviewandmetaanalysis